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S UMM A R Y
Xpertw MTB/RIF is the initial diagnostic test of choice
for tuberculosis (TB). It is not known if false-positive
results are more common in previously treated patients.
We report four patients with successful treatment for TB
up to 5 years previously who presented with respiratory
tract infection and were Xpert-positive, but had negative
TB cultures and clinical improvement without anti-
tuberculosis treatment. We hypothesise that the Xpert
results were false-positive due to the presence of dead
Mycobacterium tuberculosis bacilli in lungs and spu-
tum. Further work is required to determine the
specificity of Xpert in previously treated patients.
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THE WORLD HEALTH ORGANIZATION
(WHO) has endorsed the roll-out of Xpertw MTB/
RIF (Cepheid, Sunnyvale, CA, USA) as the initial
diagnostic test in persons suspected of having
multidrug-resistant tuberculosis (MDR-TB) or hu-
man immunodeficiency virus associated TB.1 A
recent systematic review and meta-analysis including
15 studies with 7517 participants found a pooled
sensitivity of 88% (95% credibility interval [CrI]
83–92) and pooled specificity of 98% (95%CrI 97–
99) if microscopy was replaced by Xpert as the
initial diagnostic test.2 It has not been reported
whether patients with false-positive Xpert results are
more likely to have had a previous episode of TB;
however, Xpert does not distinguish dead from living
bacilli. It is theoretically possible for the test to be
positive in patients who do not have active disease
but still have dead Mycobacterium tuberculosis
bacilli in their lungs and sputum from a previously
treated episode of active TB. In such cases, sputum
culture would be negative and the patient would not
require anti-tuberculosis treatment. This possibility
is supported by a recent study showing that after 6
months of standard treatment, 27% of patients
remain Xpert-positive, although only 4% are posi-
tive using liquid culture.3 Conversion of Xpert to
negative is therefore not a suitable marker of
treatment success, and positivity may persist despite
successful treatment.
We report four patients with a history of success-
fully treated TBwho presented with lower respiratory
tract infections, positive Xpert results, negative liquid
TB cultures and clinical improvement without anti-
tuberculosis treatment, suggesting that the Xpert
result was falsely positive.
CASE REPORT
Patient 1 was diagnosed with MDR-TB based on
sputum culture 7 years previously. She initiated a
standardised five-drug MDR-TB treatment regimen
and became culture-negative after 135 days. She
completed 18 months of treatment and achieved cure.
She later presented with a 1-week history of shortness
of breath and a productive cough. Chest X-ray
showed fibrotic changes with nodules at the hila
and right upper zone, and a diffuse infiltrate in lingula
of the left lower lobe (Figure). She was treated with
oral amoxicillin while awaiting sputum results. The
first sputum sample was Xpert-positive with rifam-
picin (RMP) resistance. She remained clinically
stable, and as her symptoms had improved, anti-
tuberculosis treatment was delayed to await the
culture results. Two sputum samples obtained at this
time were both culture-negative after 6 weeks’
incubation. On clinical re-assessment at this point,
she was asymptomatic and the lingula infiltrate on the
CXR had largely resolved (Figure). Repeat sputum
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sampling was again Xpert-positive with RMP resis-
tance, but TB liquid culture was negative. The patient
did not receive anti-tuberculosis treatment, and she
remained clinically well 5 months after initial
presentation.
Three other cases fulfilled the case definition of
having a previous episode of TB, positive Xpert
result, negative mycobacterial culture and clinical
improvement without anti-tuberculosis treatment
(Table).
DISCUSSION
We present four patients with a history of treated TB
who had completed treatment up to 5 years previ-
ously. All were Xpert-positive during an intercurrent
respiratory tract infection with negative mycobacte-
rial cultures of sputum and clinical improvement
without anti-tuberculosis treatment. We hypothesise
that these positive Xpert results indicate the presence
of mycobacterial DNA from dead bacilli persisting in
lung tissue expectorated at the time of an intercurrent
chest infection, and therefore falsely positive with
respect to the diagnosis of active TB.
Treatment algorithms suggest that all patients with
positive Xpert results should immediately start anti-
tuberculosis treatment. Only a minority who are seen
by specialists are likely to have treatment withheld
when the clinical suspicion of active TB disease is low.
As such, it is difficult to estimate the scale of the
problem, although these cases were collected within a
single city over the course of 4 months, suggesting
that it might be fairly common. It will be important to
estimate the true incidence of false-positive Xpert
results in treatment-experienced patients to avoid
unnecessary anti-tuberculosis treatment with poten-
tial side effects. If this proves to be a common
occurrence, it will be necessary to change the
treatment algorithms.
These cases suggest that the specificity of Xpert in
patients with previous TB may be lower than
previously thought. Despite a pooled specificity of
98% (95%CrI 97–99) in a recent Xpert diagnostic
accuracy study,2 there is reason to doubt this figure.
The two largest studies that contributed 5250 of the
7517 patients in the review used an imprecise
reference standard to diagnose TB.4,5 Both of these
studies described a group of patients classified as
having clinical TB with negative sputum culture. The
proportion of patients in this group with positive
Xpert results was lower than in those with positive
sputum culture. In both trials, this group was
excluded from the primary analysis and therefore
from the review. The justification for this exclusion is
unclear, but is not appropriate in a study of diagnostic
accuracy. It is possible that some patients with
positive Xpert results and negative cultures were
retreatment cases with false-positive results. Exclud-
ing such cases from the analyses and from the
systematic review would have the effect of increasing
the reported specificity of the Xpert assay.
There is an urgent need to re-examine data from all
previous diagnostic trials to include patients with
clinical TB, some of whom were Xpert-positive and
TB culture-negative, and to determine the specificity
specifically in retreatment cases when such analyses
are conducted. Further prospective studies may then
be necessary to quantify the scale of the problem, and
define in what proportion of patients Xpert remains
positive after successful anti-tuberculosis treatment
and define the duration of this phenomenon and what
factors predispose to this. Whether patients previ-
ously treated for TB may convert from Xpert-
negative to false-positive at the time of a bacterial
Figure Chest X-ray during respiratory tract infection (left) and following resolution of symptoms (right) for Case 1.
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chest infection (as in these four cases) due to lung
inflammation also needs to be investigated.
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R E S UM E
Le test Xpertw MTB/RIF est l’examen ide´al pour le
diagnostic initial de la tuberculose. On ne sait pas si les
faux positifs sont plus fre´quents chez les patients de´ja`
traite´s. Nous pre´sentons quatre patients dont le
traitement anti-tuberculeux a re´ussi jusqu’a` 5 ans
auparavant et qui se pre´sentent avec une infection
respiratoire et un test Xpert positif mais une culture
ne´gative et une ame´lioration clinique sans traitement
anti-tuberculeux. Nous e´mettons l’hypothe`se que les
re´sultats du Xpert sont des faux positifs dus a` la pre´sence
de bacilles de Mycobacterium tuberculosis morts dans
les poumons et les crachats. Un travail supple´mentaire
est ne´cessaire afin de de´terminer la spe´cificite´ du Xpert
chez des patients pre´alablement traite´s.
R E S UM E N
La prueba Xpertw MTB/RIF es el me´todo inicial de
eleccio´n en el diagno´stico de la tuberculosis (TB). Se
desconoce si los resultados positivos falsos son ma´s
frecuentes en los pacientes con antecedente de
tratamiento. En el presente artı´culo se comunican
cuatro casos de pacientes con antecedente de
tratamiento eficaz de la TB hasta 5 an˜os antes de
acudir por infeccio´n respiratoria y presentar un
resultado positivo a la prueba Xpert, con cultivo
negativo y sin respuesta clı´nica al tratamiento
antituberculoso. Se plantea la hipo´tesis de que los
resultados de la prueba fueron positivos falsos, debido
a la presencia de bacilos de Mycobacterium tuberculosis
no viables en los pulmones y el esputo. Se precisan
nuevos trabajos que determinen la especificidad del
me´todo Xpert en los pacientes previamente tratados.
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